公开(公告)号：US09773245B1

公开(公告)日：2017-09-26

申请号：US13311285

申请日：2011-12-05

Applicant: Imran S. Patel ,  Umesh Kumar ,  Gabriel E. Yeung ,  Craig R. Brookes ,  Tamal Saha

Inventor： Imran S. Patel ,  Umesh Kumar ,  Gabriel E. Yeung ,  Craig R. Brookes ,  Tamal Saha

IPC: G06Q30/00 ,  G06Q20/40 ,  G06F21/32 ,  G06F3/0488

CPC classification number: G06Q20/40 ,  G06F3/04883 ,  G06F21/31 ,  G06F21/32 ,  G06Q20/12 ,  G06Q20/3223 ,  G06Q20/405 ,  G06Q30/00

Abstract: Described herein are techniques for initiating item fulfillment at least partly in response to the users performing gestures on touchscreens of client devices. For instance, a user may operate a client device that renders content associated with an item offered by an offering service. The user may thereafter request to acquire the item by performing a gesture on a touchscreen of the client device. The offering service may receive the request and a representation of the gesture and, in response, may determine whether or not to initiate fulfillment of the item at least partly with reference to the received representation of the gesture.

公开(公告)号：US09193784B2

公开(公告)日：2015-11-24

申请号：US13491810

申请日：2012-06-08

Applicant: Stephen Anthony Burbidge ,  Jonathan Henry Ellis ,  Susannah K Ford ,  Volker Germaschewski ,  Umesh Kumar ,  Karen Louise Philpott ,  Peter Ernest Soden

Inventor： Stephen Anthony Burbidge ,  Jonathan Henry Ellis ,  Susannah K Ford ,  Volker Germaschewski ,  Umesh Kumar ,  Karen Louise Philpott ,  Peter Ernest Soden

IPC: C07K16/18 ,  A61K39/395 ,  A61K39/00

CPC classification number: C07K16/18 ,  A61K2039/505 ,  C07K2317/24 ,  C07K2317/34 ,  C07K2317/52 ,  C07K2317/71 ,  C07K2317/92 ,  C07K2317/94

Abstract: Antibodies that bind human β-amyloid peptide, methods of treating diseases or disorders characterized by elevated β-amyloid levels or β-amyloid deposits with said antibodies, pharmaceutical compositions comprising said antibodies and methods of manufacture.

Abstract translation: 结合人和淀粉样蛋白肽的抗体，以所述抗体为特征的疾病或病症的特征在于升高的淀粉样蛋白水平或淀粉样蛋白沉积物的方法，包含所述抗体的药物组合物和制备方法。

公开(公告)号：US08227576B2

公开(公告)日：2012-07-24

申请号：US12294438

申请日：2007-03-27

Applicant: Stephen Anthony Burbidge ,  Jonathan Henry Ellis ,  Susannah K Ford ,  Volker Germaschewski ,  Umesh Kumar ,  Karen Louise Philpott ,  Peter Ernest Soden

Inventor： Stephen Anthony Burbidge ,  Jonathan Henry Ellis ,  Susannah K Ford ,  Volker Germaschewski ,  Umesh Kumar ,  Karen Louise Philpott ,  Peter Ernest Soden

IPC: C12P21/08 ,  C07K16/00 ,  A61K39/395 ,  A61K39/00

CPC classification number: C07K16/18 ,  A61K2039/505 ,  C07K2317/24 ,  C07K2317/34 ,  C07K2317/52 ,  C07K2317/71 ,  C07K2317/92 ,  C07K2317/94

Abstract: Antibodies that bind human β-amyloid peptide, methods of treating diseases or disorders characterised by elevated β-amyloid levels or β-amyloid deposits with said antibodies, pharmaceutical compositions comprising said antibodies and methods of manufacture.

Abstract translation: 结合人和淀粉样蛋白肽的抗体，以所述抗体为特征的疾病或病症的特征在于淀粉样蛋白水平升高或淀粉样沉积的方法，包含所述抗体的药物组合物和制造方法。

公开(公告)号：US5759432A

公开(公告)日：1998-06-02

申请号：US663729

申请日：1996-06-14

Applicant: Umesh Kumar ,  Wayne Huebner ,  Sea Fue Wang

Inventor： Umesh Kumar ,  Wayne Huebner ,  Sea Fue Wang

IPC: B06B1/06 ,  C04B35/499 ,  H01L41/187 ,  C04B35/495 ,  C04B35/472 ,  H02K47/04

CPC classification number: B06B1/06 ,  C04B35/499 ,  H01L41/187

Abstract: A relaxor ferroelectric composition that has the components lead magnesium niobate, lead titanate, and lead magnesium tungstate. The components are preferably present in relative molar amounts of (1-x-y) lead magnesium niobate, (x) lead titanate, and (y) lead magnesium tungstate, where 0.11.ltoreq.x.ltoreq.0.13 and 0.01.ltoreq.y.ltoreq.0.03. Also disclosed is a tunable ultrasonic transducer made of a relaxor ferroelectric composition that has the components lead magnesium niobate, lead titanate, and lead magnesium tunstate. A method of making a relaxor ferroelectric material comprising the step of adding an effective amount of lead magnesium tungstate to a lead magnesium niobate-lead titanate composition is also disclosed.

Abstract translation: 具有铅铌酸铅，钛酸铅和钨酸铅镁的组分的弛豫铁电组合物。 组分优选以（1-xy）铅铌酸铅，（x）钛酸铅和（y）钨酸铅镁的相对摩尔量存在，其中0.11≤x≤0.13和0.01 < /=0.03。 还公开了一种由弛豫铁电组合物制成的可调谐超声波换能器，其具有铌酸镁镁，钛酸铅和镁镁铅组分。 还公开了一种制备弛豫铁电材料的方法，其包括将有效量的钨酸铅镁添加到铅铌酸铅铅钛酸盐组合物的步骤。